Results 161 to 170 of about 42,265 (195)
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders. [PDF]
Hall S +5 more
europepmc +1 more source
Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders. [PDF]
Almeida L +10 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Atypical Parkinsonian Disorders
Movement Disorders, 2005In many neurological diseases the topography of the lesion, whatever its nature, determines the clinical signs, whereas the nature of the lesion (vascular, inflammatory, degenerative, etc.) whatever its topography, determines the time course. According to J. P. Martin (1), this general principle cannot be simply applied to diseases of the basal ganglia
Gregor K. Wenning, Werner Poewe
+4 more sources
Neuroimaging in Parkinsonian Disorders
Neurology India, 2018Neuroimaging (NI) in Parkinson's disease (PD) includes functional techniques like positron emission tomography (PET) and single photon emission computed tomography (SPECT), and morphological imaging using magnetic resonance imaging (MRI) and transcranial sonography to probe different aspects of the neurobiology of PD.
Madhavi, Tripathi +2 more
openaire +2 more sources
Atypical Parkinsonian Disorders
Neurologic ClinicsAtypical parkinsonian disorders (APD) include progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy. Identifying APD is important because they have different pathogenesis, disease course, and prognosis than Parkinson's disease (PD), and require different treatments.
Nahid, Olfati +2 more
openaire +2 more sources
Serial volumetric MRI in Parkinsonian disorders
Movement Disorders, 2009AbstractTracking progression in neurodegenerative diseases is hampered by the limitations of the clinical rating scales, which are seldom linear, suffer from floor and ceiling effects, lack the ability to distinguish symptomatic change from disease modification, and are limited by imperfect intra‐ and inter‐rater reliability.
Wild, E.J., Fox, N.C.I.
openaire +4 more sources
ATYPICAL PARKINSONIAN DISORDERS
Continuum, 2004Atypical Parkinsonian disorders , Atypical Parkinsonian disorders , کتابخانه دیجیتال جندی شاپور ...
openaire +1 more source
Brain perfusion differences in Parkinsonian disorders
Movement Disorders, 2011AbstractWe aimed to objectively examine the brain perfusion differences between PD, Parkinson variant of multiple system atrophy, and progressive supranuclear palsy. 99mTc ethylcysteinate dimer single‐photon emission CT (SPECT) was performed in 28 patients with PD, 12 with Parkinson variant of multiple system atrophy, 19 with progressive supranuclear ...
Noriyuki, Kimura +7 more
openaire +2 more sources
Neuromelanin in parkinsonian disorders: an update
International Journal of Neuroscience, 2017Neuromelanin (NM) is a dark pigment that accumulates linearly with aging in substantia nigra (SN) and locus coeruleus (LC). The dual protective and toxic role of NM has been hypothesized according to its intraneuronal or extraneuronal deposition. The melanized dopaminergic neurons in SN and LC seem to have special vulnerability to neurodegeneration in ...
Martin-bastida, Antonio +2 more
openaire +2 more sources
Update of atypical parkinsonian disorders
Current Opinion in Neurology, 2007This timely update discusses novel diagnostic approaches, recently identified genes, and innovative experimental symptomatic treatments for these devastating disorders.Differential patterns in the basal ganglia transcranial sonography, magnetic resonance diffusion-weighted imaging regional apparent diffusion coefficients in the brainstem, basal ganglia
openaire +2 more sources

